PAHC Valuation

Add to Watchlist

Advanced Chart

0.000

0.000(0.000%)

Overview
Forecast
Valuation

PAHC Relative Valuation

PAHC's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, PAHC is overvalued; if below, it's undervalued.

Historical Valuation

Phibro Animal Health Corp (PAHC) is now in the Undervalued zone, suggesting that its current forward PE ratio of 10.36 is considered Undervalued compared with the five-year average of 14.21. The fair price of Phibro Animal Health Corp (PAHC) is between 32.86 to 44.79 according to relative valuation methord. Compared to the current price of 22.47 USD , Phibro Animal Health Corp is Undervalued By 31.62%.

Relative Value

Fair Zone

32.86-44.79

Current Price：22.47

31.62%

Undervalued

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

3.39

P/B

Median3y

2.52

Median5y

3.18

6.25

FCF Yield

Median3y

-0.38

Median5y

0.77

Competitors Valuation Multiple

The average P/S ratio for PAHC's competitors is 12.50, providing a benchmark for relative valuation. Phibro Animal Health Corp Corp (PAHC) exhibits a P/S ratio of 0.57, which is -95.44% above the industry average. Given its robust revenue growth of 32.14%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

PAHC.O

Phibro Animal Health Corp

0.57

Average P/S: 12.50

32.14%